Outlook Therapeutics reports positive results from NORSE THREE study in retinal disease
31 March 2021 - 11:20PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2024 to May 2024
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From May 2023 to May 2024